TRAF1 and cancer: In a study of 400 RA patients, Panoulas et al. found that TRAF1/C5 SNP rs3761847 GG homozygote status is also associated with an increased risk of death from sepsis or malignancies but not from cardiovascular disease in patients with established RA (70).